Kenneth M Comess

Title: Innovations of Kenneth M Comess in Anti-Cancer Research

Introduction

Kenneth M Comess is a notable inventor based in Winnetka, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antiangiogenic and anticancer properties. His work has the potential to impact cancer treatment and improve patient outcomes.

Latest Patents

Kenneth M Comess holds a patent for "Sulfonamides having antiangiogenic and anticancer activity." This patent describes compounds that inhibit methionine aminopeptidase-2 (MetAP2). The patent also includes pharmaceutical compositions that utilize these compounds, methods of treatment using the compounds, and techniques for inhibiting angiogenesis and treating cancer.

Career Highlights

Comess is associated with Abbott Laboratories Corporation, a leading global healthcare company. His work at Abbott has allowed him to focus on innovative solutions in the pharmaceutical industry. His research is aimed at developing effective treatments for cancer, showcasing his commitment to advancing medical science.

Collaborations

Throughout his career, Kenneth M Comess has collaborated with notable colleagues, including Scott A Erickson and Jack Henkin. These collaborations have contributed to the advancement of research in the field of cancer treatment.

Conclusion

Kenneth M Comess is a distinguished inventor whose work in anti-cancer research has the potential to make a significant impact on the treatment of cancer. His innovative compounds and dedication to pharmaceutical advancements highlight the importance of research in improving healthcare outcomes.